Investor Relations

Communiqués en persberichten

Oproepingsbrief Metrics in Balance NV_Buitengewone Algemene Vergadering op 29 maart 2019 & Jaarlijkse Algemene Vergadering 27 mei 2019

Oproepingsbrief Jaarlijkse Algemene Vergadering Metrics in Balance NV_28 mei 2018

Press release Metrics in Balance N.V. – Listing on Euronext AccessTM in Paris

Document de présentation – mars 2018

Publications Belgian Official Gazette

Directors

• Dirk Verstraete, managing director
• Guy De Vreese, managing director
• Philippe Van Acker, director
• Cavalli Consulting BVBA, represented by Marc Gryspeerdt, director

Shareholder’s Structure

• Share capital: EUR 12.438.001,27
• Number of outstanding shares as of March 29, 2019: 4.390.523
• Number of voting rights as of March 29, 2019: 4.390.523
• Each of the shares carries one voting right at the general meeting of shareholders No outstanding options or warrants have been issued that entitle their holder to shares, nor shares without voting rights.
• Currently (April 23th, 2018) there are no shareholders owning more than 25% of the share capital or voting rights
• Ultimate Beneficial Owner (UBO)
  

  On March 29th, 2019 REMEDENT NV became a shareholder with more than 25% of the share capital or voting rights of Metrics in Balance NV (“MiB”), through to the capital increase in kind that took place on that day.
  
  On March 29th, 2019 REMEDENT NV held 1.316.546 MiB shares representing circa 29,99% of MiB’s total share capital and voting rights.
  
  REMEDENT NV is for 99,99% owned by the American company Remedent Inc. stock listed on Nasdaq (https://www.nasdaq.com/markets/spos/company/remedent-inc-71235-55437).
  According to the last know shareholders’ records of Remedent Inc. dating from May 8th, 2018, no shareholder was owner of more than 25% of the shares of Remedent Inc.
  
  Since Mr. De Vreese is director of Remedent Inc., Mr. Guy De Vreese will be indicated as an indirect UBO of Metrics in Balance NV.